Medical Device Network on MSN
LEX Diagnostics secures FDA clearance for VELO PCR system
The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.
The Canada Point of Care Molecular Diagnostics Market, valued at USD 350 million in 2024, is projected to reach USD 560 ...
Global Molecular Infectious Disease Testing Market OverviewThe global molecular infectious disease testing market is ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announces it has received validation from AOAC International for its ...
Gene expression experiments measure changes in RNA transcript levels to compare how genes are up- or down-regulated across ...
On February 13, 2026, Mainz Biomed N.V. (the “Company”) entered into a securities purchase agreement for a 6.0 USD million private placement with investor David Lazar. The financing will be completed ...
Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...
ProbeLibrary, a fast, specific and flexible format for quantitative real-time PCR, is described. The ProbeLibrary concept is based on the fact that just 90 short probes provide transcriptome-wide ...
To validate our technique, we selected alveolar macrophages as target cells, which contain transcriptionally inducible genes and may—apart from cell picking—be alternatively acquired from the same ...
Fill out the form below and we'll send your colleague an invitation to the "Enhancing qPCR Assay Development: Strategies for Successful Multiplexing" event. Multiplexing in qPCR enables researchers to ...
NEW YORK – Lex Diagnostics said on Monday that it has obtained 510 (k) clearance and CLIA waiver from the US Food and Drug Administration for its Velo point-of-care molecular diagnostic system and an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results